Otonomy Inc logo

Otonomy Inc

$ 0.28 +0.0137 (+5.13%) 10:08 PM EST
P/E:
At Loss
P/B:
0.48
Market Cap:
$ 16.00M
Enterprise V:
$ -6.95M
Volume:
318.43K
Avg Vol (2M):
897.06K
Also Trade In:
Volume:
318.43K
Market Cap $:
16.00M
PE Ratio:
At Loss
Avg Vol (2-Month):
897.06K
Enterprise Value $:
-6.95M
PB Ratio:
0.48
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Otonomy Inc is a biopharmaceutical company, focuses on the development and commercialization of therapeutics for diseases and disorders of the ear. It offers OTIPRIO, a ciprofloxacin otic suspension for use during tympanostomy tube placement surgery in pediatric patients. The company also develops OTO-104, a sustained-exposure formulation of the steroid dexamethasone for the treatment of Meniere's disease and other inner ear conditions; and OTO-311, a sustained-exposure formulation for the treatment of tinnitus. All the business activity primarily operates through the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.72
Equity-to-Asset 0.45
Debt-to-Equity 0.97
Debt-to-EBITDA -0.61
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -5.01
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 46.91
9-Day RSI 40.27
14-Day RSI 34.3
6-1 Month Momentum % -85.48
12-1 Month Momentum % -79.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.83
Quick Ratio 4.83
Cash Ratio 4.56

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.7
Name Current Vs Industry Vs History
ROE % -96.73
ROA % -56.73
ROIC % -241.82
ROC (Joel Greenblatt) % -356.46
ROCE % -61.93

Financials (Next Earnings Date:2022-11-10 Est.)

OTIC's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:OTIC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.78
Beta 1.33
Volatility % 84.19
14-Day RSI 34.3
14-Day ATR ($) 0.045081
20-Day SMA ($) 0.30778
12-1 Month Momentum % -79.34
52-Week Range ($) 0.24 - 2.5899
Shares Outstanding (Mil) 56.99

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Otonomy Inc Filings

Document Form Filing Date
No Filing Data

Otonomy Inc Analysis

Share your research

Headlines

See More
No news.